US Patent Issued to Dexcom on May 5 for "Therapeutic zone assessor" (Virginia Inventor)

ALEXANDRIA, Va., May 5 -- United States Patent no. 12,620,469, issued on May 5, was assigned to Dexcom Inc. (San Diego).

"Therapeutic zone assessor" was invented by Stephen D. Patek (Charlottesville, Va.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Systems and methods are provided for identifying therapeutic zones where there is glycemic dysfunction of a specific type that can be addressed by making strategic changes to behavior and/or therapy parameters. Systems and methods described herein evaluate large historical data sets to: identify a therapeutic zone or zones with glycemic dysfunction that are most readily addressable; quantify the glycemic impact of a plurality of different therapeutic adjustments...